Moonwalk Biosciences Launches with $57 Million in Financing to Advance a New Class of Precision Epigenetic Medicines

SOUTH SAN FRANCISCO, Calif. & SAN DIEGO–(BUSINESS WIRE)–Moonwalk Biosciences Launches with $57 Million in Financing to Advance a New Class of Precision Epigenetic Medicines
Click here to view original post